Clinical Trials Sponsored by Opsens, Inc.

Total 36119 results

Ipsen

Completed

Efficacy and Tolerability of Lanreotide (Autogel 120 mg) in Patients With Acromegaly

Acromegaly

Italy
Ipsen

Completed

Lanreotide Autogel in the Symptomatic Treatment of Refractory Diarrhea (MEDARD)

Diarrhea

Belgium
Ipsen

Completed

Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study (SODA)

Acromegaly

United States
Ipsen

Completed

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

Metastatic Renal Cell Cancer | Advanced or Metastatic Hepatocellular Cancer | Advanced or Metastatic Ovarian Cancer | Advanced or Metastatic Gastric Carcinoma

Belgium, Canada, France, Spain, United Kingdom
Ipsen

Completed

Eziclen Drug Utilisation in Real Life Setting (DUS-BLI800)

Bowel Cleansing

Netherlands, Czechia, Germany, Poland
Ipsen

Completed

Study in Polish Acromegalic Patients Treated With Somatuline Autogel

Acromegaly

Poland
Ipsen

Completed

A Post Marketing Surveillance Program for NutropinAq® in Paediatric Growth Disorders (iNCGS)

Growth Hormone Disorders

United Kingdom
Ipsen

Completed

Non Interventional Post Marketing Programme in Acromegaly

Acromegaly

United Kingdom
Ipsen

Completed

Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain (RECOSY)

Neuroendocrine Tumors

Spain
Ipsen

Completed

Study to Document the Effectiveness of Dysport in Patients Suffering From Upper Limb Spasticity (ULS) After Stroke (PSAS REGISTRY)

Post Stroke Arm Spasticity

Poland
Ipsen

Completed

Study of Diphereline 3.75 mg Treatment In Women Suffering From Internal Genital Endometriosis

Internal Endometriosis

Russian Federation
Ipsen

Completed

Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients (B-CAUSE)

Spasticity

Brazil
Christian Olsen
University of Copenhagen; University Hospital Bispebjerg and Frederiksberg; Regionshospitalet... and other collaborators

Unknown

Management of Acute Lateral Ankle Sprains

Ankle Sprains

Denmark
Corsens Medical LTD

Unknown

Determining the Optimal Cut-off Point of PEA by Corsens Device for Discriminating Between MI and Non-MI Subjects

Myocardial Infarction
Albireo

Approved for marketing

Odevixibat for the Treatment of Progressive Familial Intrahepatic Cholestasis

Progressive Familial Intrahepatic Cholestasis

United States
Albireo

Completed

A4250, an IBAT Inhibitor in Pediatric Cholestasis

Pediatric Cholestasis

United Kingdom, Denmark, France, Germany, Sweden
Albireo

Completed

Double-blind, Randomised Study of A3384 in BAM/BAD

Bile Acid Malabsorption

Sweden, United Kingdom
GTx
Ipsen

Withdrawn

Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate Cancer (TREAT2)

Risk of Bone Fracture Occurrences

United States
Albireo

Recruiting

Efficacy and Safety of Odevixibat in Children With Biliary Atresia Who Have Undergone a Kasai HPE (BOLD)

Biliary Atresia

Netherlands, United States, Spain, Italy, Taiwan, Korea, Republic of, France, Germany, United Kingdom, Canada, Belgium, China, Australia, Poland, Turkey, Malaysia, New Zealand, Hungary, Israel
Albireo

Enrolling by invitation

An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia (BOLD-EXT)

Biliary Atresia

Spain, United States, Netherlands, Malaysia, Canada, Germany, Turkey, Italy, France, Australia, Poland, New Zealand
Albireo

Active, not recruiting

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Progressive Familial Intrahepatic Cholestasis

United States, Spain, Netherlands, United Kingdom, Turkey, Canada, Italy, Germany, France, Israel, Australia, Belgium, Poland, Saudi Arabia, Sweden
Exelixis
Ipsen

Active, not recruiting

A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy

Differentiated Thyroid Cancer

Hong Kong, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Croatia, Czechia, France, Germany, Hungary, Israel, Korea, Republic of, Mexico, Netherlands, Poland, Romania, Russian Federation, Spain, Taiwan, ... and more
Albireo

Completed

Study of A3309 in Patients With Dyslipidemia

Dyslipidemia

Sweden
Albireo

Completed

Efficacy and Safety of Odevixibat in Patients With Alagille Syndrome (ASSERT)

Alagille Syndrome

United States, United Kingdom, France, Germany, Canada, Netherlands, Italy, Malaysia, Belgium, Israel, New Zealand, Poland, Turkey
UNICANCER
Ipsen

Active, not recruiting

Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

Prostate Cancer

France
Opsona Therapeutics Ltd.

Completed

Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function

Delayed Graft Function

United States, Spain, Belgium, Switzerland, France, Germany, United Kingdom, Poland, Netherlands, Austria, Czech Republic
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
Albireo

Recruiting

Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis

Primary Sclerosing Cholangitis

Spain, Italy, France
Albireo

Active, not recruiting

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome (ASSERT-EXT)

Alagille Syndrome

United Kingdom, United States, France, Germany, Netherlands, Italy, Belgium, Malaysia, Poland, Turkey
Albireo

Completed

An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects

Primary Biliary Cirrhosis | Alagille Syndrome | Progressive Familial Intrahepatic Cholestasis | Orphan Cholestatic Liver Diseases

United Kingdom
Albireo

Completed

A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384

Primary Biliary Cirrhosis | Alagille Syndrome | Progressive Familial Intrahepatic Cholestasis | Orphan Cholestatic Liver Diseases
i-SENS, Inc.
Avania; Rainier Clinical Research Center

Terminated

Method Comparison/User Evaluation of the i-SENS Self-Monitoring Blood Glucose / β-Ketone System

Diabetes

United States
Apsen Farmaceutica S.A.

Recruiting

Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction (CARLOTA)

Postsurgical Pain | Third Molar Extraction

Brazil
Apsen Farmaceutica S.A.

Completed

Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin

Vertigo, Peripheral

Brazil
Apsen Farmaceutica S.A.

Withdrawn

Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease

Vertigo | Meniere Disease | Vertigo Vestibular
Apsen Farmaceutica S.A.

Completed

Phase I Study to Evaluate the Safety of Dexibuprofen 300mg Under Fasting and Fed Conditions

Healthy Volunteers

Brazil
Emory University
Ipsen

Completed

Dysport for the Treatment of OMD

Tardive Dystonia | Oral Dystonia

United States
Yale University
Ipsen

Terminated

Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain

Lower Back Pain

United States
Albireo
Celerion

Completed

Study of A4250 in Healthy Volunteers Under Fasting, Fed and Sprinkled Conditions

Healthy Volunteers

United States
Apsen Farmaceutica S.A.

Completed

Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain (APS003/2020)

Osteoarthritis

Brazil
Apsen Farmaceutica S.A.

Completed

Phase I Study to Evaluate the Safety of Dexibuprofen 200mg Under Fasting and Fed Conditions

Healthy Volunteers

Brazil
Northwell Health
Ipsen

Completed

Lanreotide in the Treatment of Small Bowel Motility Disorders

Intestinal Disease | Gastrointestinal Motility Disorder

United States
Jeppe Lange

Completed

Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease

Dupuytren Contracture
Horsens Hospital
University of Aarhus

Recruiting

Hip Abductor Tendon Repair Versus Sham Surgery

Rupture of Hip Abductor Tendon (Disorder)

Denmark
University of Aarhus
Horsens Hospital

Terminated

Complications Related to Arthroscopic Surgery of the Hip - a Prospective Cohort Study

Femoracetabular Impingement | Hip Pathology

Denmark
Emory University
Ipsen

Recruiting

Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A (CECS)

Compartment Syndrome of Leg

United States
Georgetown University
Ipsen

Recruiting

NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer

Advanced Biliary Tract Cancer

United States
Columbia University
Ipsen

Active, not recruiting

Treatment Patterns and Treatment Outcomes for Acromegaly

Acromegaly

United States
Apsen Farmaceutica S.A.

Completed

Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain (APS002/2020)

Low Back Pain | Low Back Pain, Mechanical | Acute Low Back Pain

Brazil
Apsen Farmaceutica S.A.

Terminated

Phase III Efficacy and Tolerability Trial of the Fixed Dose Combination of Etodolac 400 mg and Cyclobenzaprine 10 mg Versus Isolated Active Substances in Pain Control After Impacted Third Molar Extraction (FDCETCB-III)

Pain, Acute

Brazil

Clinical Trials Sponsored by Opsens, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations